미국의 결찰기 시장 : 규모, 점유율, 동향 분석, 제품별, 용도별, 수기별, 최종 용도별, 부문 예측(2025-2033년)

U.S. Ligation Devices Market Size & Trends:

The U.S. ligation devices market size was estimated at USD 619.9 million in 2024 and is expected to grow at a CAGR of 6.7% from 2025 to 2033 to reach a value of USD 1,108.6 million in 2033. The market growth is driven by several factors, including the increasing volume of surgical procedures, fueled by an aging population and the rising prevalence of chronic diseases such as cardiovascular conditions and cancer. Technological advancements, such as robotic-assisted ligation systems and the development of innovative materials, enhance surgical precision and patient outcomes, further fueling market expansion.

The growing preference for minimally invasive surgical techniques also contributes to market growth, as ligation devices are essential. The U.S. is witnessing a significant rise in overall surgical interventions owing to the aging population and the rising prevalence of chronic and degenerative diseases. As the proportion of Americans aged 65 and older continues to increase, there is a corresponding rise in age-related conditions such as cardiovascular disease, colorectal cancer, and urologic disorders, which significantly increases demand for surgical treatment involving ligation. According to the Population Reference Bureau (PRB), the elderly population in the U.S. aged 65 years is expected to increase from around 58 million in 2022 to approximately 82 million by 2050. Geriatric patients undergoing procedures such as bowel resections, hernia repairs, and prostatectomies benefit from the reduced operative time and lower risk of complications offered by advanced ligation systems.

Moreover, procedures in gastrointestinal, gynecological, cardiovascular, and urological specialties are witnessing a surge due to the growing burden of conditions such as cancer, diabetes, and heart disease. According to the American Heart Association (AHA), in January 2024, someone dies of a stroke every 3 minutes and 14 seconds, highlighting the urgent need for timely surgical management. This expanding surgical demand is prompting medical device companies to invest in advanced ligation technologies that support efficiency and patient safety in high-volume surgical environments. For instance, in February 2024, Ethicon (a Johnson & Johnson MedTech company) announced enhancements to its surgical stapling and ligation devices, optimized for precision and tissue management during minimally invasive surgeries. Similarly, Medtronic is expanding its vessel sealing product line to support broader applications in laparoscopic and open surgeries, addressing the needs of growing procedure volumes.

U.S. Ligation Devices Market Report Segmentation

This report forecasts revenue growth at country levels and analyzes the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. ligation devices market report based on product, application, procedure, and end use:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Appliers
  • Disposable
  • Reusable
• Accessories
  • Clips
  • Clip remover
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Gastrointestinal and abdominal
• Gynecological
• Cardiothoracic
• Urological
• Bariatric
• Vascular
• Other
• Procedure Outlook (Revenue, USD Million, 2021 - 2033)
• Minimally Invasive Surgery
  • Laparoscopic
  • Robotic Assisted
  • Others
• Open surgery
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Others

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Product Segment
  • 1.2.2. Application Segment
  • 1.2.3. Procedure Segment
  • 1.2.4. End Use Segment
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives
  • 1.10.1. Objective 1
  • 1.10.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. U.S. Ligation Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. The increasing volume of surgical procedures
    • 3.2.1.2. Technological advancements in material
    • 3.2.1.3. The growing preference for minimally invasive surgical techniques
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of advanced ligation devices
• 3.3. Ligation Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis

Chapter 4. U.S. Ligation Devices Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Ligation Devices Market Product Movement Analysis
• 4.3. U.S. Ligation Devices Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Appliers
  • 4.4.1. Appliers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.4.2. Disposable
    • 4.4.2.1. Disposable market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.4.3. Reusable
    • 4.4.3.1. Reusable market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 4.5. Accessories
  • 4.5.1. Accessories market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5.2. Clips
    • 4.5.2.1. Clips market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5.3. Clip remover
    • 4.5.3.1. Clip remover market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Ligation Devices Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Ligation Devices Market Application Movement Analysis
• 5.3. U.S. Ligation Devices Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 5.4. Gastrointestinal and abdominal
  • 5.4.1. Gastrointestinal and abdominal market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 5.5. Gynecological
  • 5.5.1. Gynecological market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 5.6. Cardiothoracic
  • 5.6.1. Cardiothoracic market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 5.7. Urological
  • 5.7.1. Urological market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 5.8. Bariatric
  • 5.8.1. Bariatric market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 5.9. Vascular
  • 5.9.1. Vascular market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 5.10. Other
  • 5.10.1. Other market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Ligation Devices Market: Procedure Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. Ligation Devices Market Procedure Movement Analysis
• 6.3. U.S. Ligation Devices Market Size & Trend Analysis, by Procedure, 2021 to 2033 (USD Million)
• 6.4. Minimally invasive surgery
  • 6.4.1. Minimally invasive surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4.2. Laparoscopic
    • 6.4.2.1. Laparoscopic market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4.3. Robotic Assisted
    • 6.4.3.1. Robotic Assisted market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.4.4. Others
    • 6.4.4.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 6.5. Open surgery
  • 6.5.1. Open surgery market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Ligation Devices Market: End-use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. U.S. Ligation Devices Market End-use Movement Analysis
• 7.3. U.S. Ligation Devices Market Size & Trend Analysis, by End-use, 2021 to 2033 (USD Million)
• 7.4. Hospitals
  • 7.4.1. Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 7.5. Ambulatory Surgical Centers (ASCs)
  • 7.5.1. Ambulatory Surgical Centers (ASCs) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
• 7.6. Others
  • 7.6.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company/Competition Categorization
• 8.2. Strategy Mapping
• 8.3. Company Market Position Analysis, 2024
• 8.4. Company Profiles/Listing
  • 8.4.1. Medtronic plc
    • 8.4.1.1. Company overview
    • 8.4.1.2. Financial performance
    • 8.4.1.3. Product benchmarking
    • 8.4.1.4. Strategic initiatives
  • 8.4.2. Johnson & Johnson (Ethicon Inc.)
    • 8.4.2.1. Company overview
    • 8.4.2.2. Financial performance
    • 8.4.2.3. Product benchmarking
    • 8.4.2.4. Strategic initiatives
  • 8.4.3. Teleflex Inc.
    • 8.4.3.1. Company overview
    • 8.4.3.2. Financial performance
    • 8.4.3.3. Product benchmarking
    • 8.4.3.4. Strategic initiatives
  • 8.4.4. B. Braun Melsungen AG
    • 8.4.4.1. Company overview
    • 8.4.4.2. Financial performance
    • 8.4.4.3. Product benchmarking
    • 8.4.4.4. Strategic initiatives
  • 8.4.5. Olympus Corporation
    • 8.4.5.1. Company overview
    • 8.4.5.2. Financial performance
    • 8.4.5.3. Product benchmarking
    • 8.4.5.4. Strategic initiatives
  • 8.4.6. Boston Scientific Corporation
    • 8.4.6.1. Company overview
    • 8.4.6.2. Financial performance
    • 8.4.6.3. Product benchmarking
    • 8.4.6.4. Strategic initiatives
  • 8.4.7. ConMed Corporation
    • 8.4.7.1. Company overview
    • 8.4.7.2. Financial performance
    • 8.4.7.3. Product benchmarking
    • 8.4.7.4. Strategic initiatives
  • 8.4.8. Applied Medical Resources Corp.
    • 8.4.8.1. Company overview
    • 8.4.8.2. Financial performance
    • 8.4.8.3. Product benchmarking
    • 8.4.8.4. Strategic initiatives
  • 8.4.9. Wexler Surgical
    • 8.4.9.1. Company overview
    • 8.4.9.2. Financial performance
    • 8.4.9.3. Product benchmarking
    • 8.4.9.4. Strategic initiatives
  • 8.4.10. Medical Disposables Corp.
    • 8.4.10.1. Company overview
    • 8.4.10.2. Financial performance
    • 8.4.10.3. Product benchmarking
    • 8.4.10.4. Strategic initiatives